FEIBA 100 U / ml powder and solvent for solution for infusion

Licence status
Authorised: 19/07/2024
Active substances
Factor VIII inhibitor bypassing fraction
Dosage Form
Powder and solvent for solution for infusion
Licence number
PA2004/001/003
Licence holder
Baxalta Innovations GmbH

Product documents

Licence information

ATC code
B02BD03 factor VIII inhibitor bypassing activity
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Marketed
Advertising conditions
Advertising to healthcare professionals only
Licence issued
19/07/2024